Wildcat Capital Management, LLC Nu Cana PLC Transaction History

Wildcat Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$4.38 - $7.0 $559,790 - $894,642	-127,806 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$4.4 - $5.59 $152,556 - $193,816	-34,672 Reduced 21.34%	127,806 $574,000
Q1 2020 Apr 09, 2020	SELL	$4.02 - $9.05 $1.47 Million - $3.3 Million	-365,009 Reduced 69.2%	162,478 $947,000
Q3 2019 Nov 14, 2019	BUY	$6.95 - $10.71 $3.67 Million - $5.65 Million	527,487 New	527,487 $3.82 Million

3.34M

Ticker NCNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,196,000
Market Cap $112M
Description
NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors; Phase Ib for patients ...

Get notified when there are updates to the investment portfolio of Wildcat Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Wildcat Capital Management, LLC with notifications on news.